Scientists at the Indian Institute of Science (IISc) have developed a new approach to potentially detect and kill cancer cells, especially those that form a solid tumor mass. They have created hybrid nanoparticles made of ...
A new nanocomplex renders a tumor harmless—and, on top of that, it trains the immune system to detect and eliminate metastases.
Oregon State University scientists have produced a proof of concept for a new and better way of caring for women facing the life-threatening situation of ectopic pregnancy, which occurs when a fertilized egg implants somewhere ...
New research has shown how microbubbles carrying powerful cancer drugs can be guided to the site of a tumor using antibodies.
Chemists funded by the SNSF have created a new compound for flexible drug delivery that specifically targets prostate cancer cells. Incorporating four different molecules, the compound prevents tumor cells from multiplying, ...
An international team in which a UPM researcher is involved has shown that it is possible to mechanically destroy cancer cells by rotating magnetic nanoparticles attached to them in elongated aggregates.
Microscopic drug molecules could soon be sent into the body to fight disease and their journey tracked using photo-acoustic imaging, after researchers developed a smart material that can locate and image cancer sites inside ...
Rheumatoid arthritis (RA), known as "immortal cancer," is a chronic, progressive autoimmune inflammatory disease. The development and application of an RA high-sensitivity theranostics probe can help to accurately monitor ...
Biophysicists have developed a method for modifying the surface of micro- and nanoparticles—tiny structures measuring between a thousandth and a millionth of a millimeter —by covering them with biological molecules. Engineered ...
Biomedical polymers have been extensively developed for promising applications in a lot of biomedical fields, such as drug delivery, disease detection/diagnosis, biosensing, regenerative medicine, and disease treatment. For ...
